Selection of Indications. On or before the second anniversary of the Effective Date, Warner shall notify GenVec of any specific indications (other than CAD and PVD) which Warner wishes to retain in the Field. The first indication so selected by Warner shall automatically be included in the Field and Warner's obligation to provide funding for the Research Program and Development shall be increased as set forth in Section 6.3.2(b). Each additional specific indication so selected by Warner shall automatically be included in the Field and Warner's obligation to provide funding under Section 6.3 shall increase by * per year per indication. Concurrently with its notice to GenVec of any indication that Warner wishes to retain in the Field, Warner shall provide to GenVec a proposed research plan for the conduct of research with respect thereto through the identification of a Development Candidate for each such indication in connection with the Research Program, and the Parties shall negotiate in good faith regarding the specific activities to be conducted in the Research Program with respect thereto. A research plan for such activities and the criteria for the applicable milestone subject to Section 6.4.3 shall be agreed to by the Research Management Committee within ninety (90) days of Warner's notice to GenVec regarding its election of the applicable indication. The Parties agree that the payments to be made by Warner to GenVec with respect to Collaboration Products for each such indication shall include milestone payments and payments for royalties and transfer pricing for such Collaboration Product, in each case, which shall be equal to those payments provided in Sections 6.4, 6.5 and 11.1 herein, respectively, unless otherwise agreed by the Parties.

Selection of Indications. The licences granted under Clause 4.1 are limited to the Indications that Oxxon selects in accordance with the provisions of this Clause 4.3, as follows:

Selection of Indications. The Parties agree that each Product may be effective for the treatment of Indications in the field of [***] diseases, but not limited to, rheumatoid arthritis, COPD, asthma, psoriasis, multiple sclerosis [***] diseases, and that it is in the best interest of both Parties to develop such Product broadly in multiple Indications subject to reasonable commercial and technical considerations. The Parties further agree to pursue a development strategy that initially focuses on the clinical development of the MT203 Product in [***] , and subject to reasonable commercial and technical considerations to expand the Development Plan to include additional Indications following the achievement of clinical proof of principle of such Product in [***] in a clinical trial. To that end, the Parties agree to include in the Development Plan the performance of development activities designed to establish in preclinical models proof of concept of the effectiveness of such Product in two other Indications. Such development activities shall be performed in parallel with the development of the MT203 Product in [***] . If the Parties achieve such preclinical proof of concept with one or more such additional Indications, the Development Plan shall be amended to include the development of the *** Certain information in this document has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. MT203 Product in such additional Indications, subject to reasonable commercial and technical considerations, promptly after the achievement of proof of principle of such Product [***] in a clinical trial.

Related to Selection of Indications

Selection of Interest Periods (a) A Borrower (or the Company on behalf of a Borrower) may select an Interest Period for a Loan in the Utilisation Request for that Loan.
Selection of Independent Counsel If the determination of entitlement to indemnification pursuant to Section 6.2 will be made by an Independent Counsel, the Independent Counsel will be selected as provided in this Section 6.3. The Independent Counsel will be selected by the Company (unless the Company requests that such selection be made by the Indemnitee, in which event the immediately following sentence will apply), and the Company will give written notice to Indemnitee advising Indemnitee of the identity of the Independent Counsel so selected. If the Independent Counsel is selected by the Indemnitee, Indemnitee will give written notice to the Company advising of the identity of the Independent Counsel so selected. In either event, Indemnitee or the Company, as the case may be, may, within ten days after such written notice of selection is given, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined in this Agreement, and the objection will set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected will act as Independent Counsel. If a written objection is made and substantiated, the Independent Counsel selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is without merit. If, within 30 days after submission by Indemnitee of a written request for indemnification pursuant to Section 6.1, no Independent Counsel is selected, or an Independent Counsel for which an objection thereto has been properly made remains unresolved, either the Company or Indemnitee may petition a court of competent jurisdiction for resolution of any objection which has been made by the Company or Indemnitee to the other’s selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the court or by such other person as the court may designate, and the person with respect to whom all objections are so resolved or the person so appointed will act as Independent Counsel under Section 6.2. The Company will pay any and all reasonable and necessary fees and expenses incurred by such Independent Counsel in connection with acting pursuant to Section 6.2 hereof, and the Company will pay all fees and expenses incident to the procedures of this Section 6.3, regardless of the manner in which such Independent Counsel was selected or appointed.
Selection of Interest Rate Options At any time any portion of this Note bears interest determined in relation to LIBOR, it may be continued by Borrower at the end of the Fixed Rate Term applicable thereto so that all or a portion thereof bears interest determined in relation to the Prime Rate or to LIBOR for a new Fixed Rate Term designated by Borrower. At any time any portion of this Note bears interest determined in relation to the Prime Rate, Borrower may convert all or a portion thereof so that it bears interest determined in relation to LIBOR for a Fixed Rate Term designated by Borrower. At such time as Borrower requests an advance hereunder or wishes to select a LIBOR option for all or a portion of the outstanding principal balance hereof, and at the end of each Fixed Rate Term, Borrower shall give Bank notice specifying: (i) the interest rate option selected by Borrower; (ii) the principal amount subject thereto; and (iii) for each LIBOR selection, the length of the applicable Fixed Rate Term. Any such notice may be given by telephone (or such other electronic method as Bank may permit) so long as, with respect to each LIBOR selection, (A) if requested by Bank, Borrower provides to Bank written confirmation thereof not later than three (3) Business Days after such notice is given, and (B) such notice is given to Bank prior to 10:00 a.m. on the first day of the Fixed Rate Term, or at a later time during any Business Day if Bank, at it’s sole option but without obligation to do so, accepts Borrower’s notice and quotes a fixed rate to Borrower. If Borrower does not immediately accept a fixed rate when quoted by Bank, the quoted rate shall expire and any subsequent LIBOR request from Borrower shall be subject to a redetermination by Bank of the applicable fixed rate. If no specific designation of interest is made at the time any advance is requested hereunder or at the end of any Fixed Rate Term, Borrower shall be deemed to have made a Prime Rate interest selection for such advance or the principal amount to which such Fixed Rate Term applied.
Notification of Interest Periods and rates of normal interest The Agent shall notify the Borrower and each Lender of:
Application of Interest Drawings Notwithstanding anything to the contrary contained in this Agreement, (i) all payments received by the Subordination Agent in respect of an Interest Drawing under the Class A Liquidity Facility and all amounts withdrawn by the Subordination Agent from the Class A Cash Collateral Account, and payable in each case to the Class A Certificateholders or the Class A Trustee, shall be promptly distributed to the Class A Trustee and (ii) all payments received by the Subordination Agent in respect of an Interest Drawing under the Class B Liquidity Facility and all amounts withdrawn by the Subordination Agent from the Class B Cash Collateral Account, and payable in each case to the Class B Certificateholders or the Class B Trustee, shall be promptly distributed to the Class B Trustee.
Determination of Interest Periods Every Interest Period shall be of the duration specified by the Borrowers pursuant to clause 3.2 but so that:
Section 310 Computation of Interest Except as otherwise specified as contemplated by Section 301 for Securities of any series, interest on the Securities of each series shall be computed on the basis of a 360-day year of twelve 30-day months.
Condition of Improvements The Improvements and the Tangible Personal Property (including but not limited to the mechanical systems, plumbing, electrical, wiring, appliances, fixtures, heating, air conditioning and ventilating equipment, elevators, boilers, equipment, roofs, structural members and furnaces) shall be in the same condition at Closing as they are as of the date hereof, reasonable wear and tear excepted. Prior to Closing, the Contributor shall not have diminished the quality or quantity of maintenance and upkeep services heretofore provided to the Real Property and the Tangible Personal Property and the Contributor shall not have diminished the Inventory. The Contributor shall not have removed or caused or permitted to be removed any part or portion of the Real Property or the Tangible Personal Property unless the same is replaced, prior to Closing, with similar items of at least equal quality and acceptable to the Acquiror.
Duration of Interest Periods The duration of each Interest Period relating to the Advance shall, save as otherwise provided herein, be one, three, six or twelve months, or any such other period as may be agreed from time to time between the Borrower and the Agent, in each case as the Borrower may select by not less than three business days' prior notice to the Agent Provided that:
Notification of Interest Periods and interest rate The Agent shall notify the Borrowers and the Banks promptly of the duration of each Interest Period and of each rate of interest (or, as the case may be default interest) determined by it under this clause 3.

Selection of Indications Sample Clauses

Filter & Search

Related Clauses

Parent Clauses

Related to Selection of Indications